Effect of Platelet-Rich Plasma Injections on Pain Reduction in Patients with Temporomandibular Joint Osteoarthrosis: A Meta-Analysis of Randomized Controlled Trials

Aims: To study the effect of platelet-rich plasma (PRP) injections on pain reduction in patients with temporomandibular joint osteoarthritis (TMJ OA). Methods: The authors performed a comprehensive search of the MEDLINE, PubMed, and Web of Science databases to retrieve RCTs published up to July 2018. Pain outcomes (visual analog scale scores) were extracted to assess the effect of PRP injections on TMJ OA. All data analyses were conducted using RevMan 5.3. Results: Six studies were included. According to the results of these trials, intra-articular injections of PRP were more effective than placebo for pain reduction (6 months postinjection: mean difference [MD] −2.82, 95% CI −3.39 to −2.25, P < .00001; 12 months postinjection: MD −3.29; 95% CI −4.07 to −2.52, P < .00001). Additionally, the comparison between PRP and hyaluronic acid injections showed a statistically significant difference in pain reduction in support of PRP (MD −0.81; 95% CI −1.22 to −0.40; P = .0001) at 12 months postinjection. All trials revealed a moderate risk of bias. Conclusion: Based on current evidence, PRP injections may reduce pain more effectively than placebo injections in TMJ OA at 6 months (level of evidence: moderate) and 12 months (level of evidence: moderate) postinjection. This significant difference in pain reduction could also be seen when PRP was compared to hyaluronic acid at 12 months postinjection (level of evidence: low). It can be cautiously interpreted that PRP has a beneficial effect on the relief of TMJ OA pain. Large-scale, low-bias RCTs are needed to test whether PRP injection should be a routine treatment for patients with TMJ OA.

meta-analysis; myofascial; pain; platelet-rich plasma; temporomandibular disorders

1. Ghosh P, Smith M. Osteoarthritis, genetic and molecular mechanisms. Biogerontology 2002;3:85–88.

2. Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008;22:351–384.

3. Cömert Kiliç S, Güngörmüs¸ M, Sümbüllü MA. Is arthrocen-tesis plus platelet-rich plasma superior to arthrocentesis alone in the treatment of temporomandibular joint osteoarthritis? A randomized clinical trial. J Oral Maxillofac Surg 2015; 73:1473–1483.

4. Guarda-Nardini L, Cadorin C, Frizziero A, Ferronato G, Manfredini D. Comparison of 2 hyaluronic acid drugs for the treatment of temporomandibular joint osteoarthritis. J Oral Maxillofac Surg 2012;70:2522–2530.

5. Anitua E, Sánchez M, Nurden AT, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) 2007;46:1769–1772.

6. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plas-ma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 2010;38:255–262.

7. Anitua E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14:529–535.

8. Lee HR, Park KM, Joung YK, Park KD, Do SH. Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2. J Control Release 2012;159:332–337.

9. Cömert Kiliç S, Güngörmüs¸ M. Is arthrocentesis plus platelet-rich plasma superior to arthrocentesis plus hyaluronic acid for the treatment of temporomandibular joint osteoarthritis: A randomized clinical trial. Int J Oral Maxillofac Surg 2016;45:1538–1544.

10. Hancı M, Karamese M, Tosun Z, Aktan TM, Duman S, Savaci N. Intra-articular platelet-rich plasma injection for the treatment of temporomandibular disorders and a comparison with arthrocentesis. J Craniomaxillofac Surg 2015;43:162–166.

11. Hegab AF, Ali HE, Elmasry M, Khallaf MG. Platelet-rich plasma injection as an effective treatment for temporomandibular joint osteoarthritis. J Oral Maxillofac Surg 2015;73:1706–1713.

12. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions (version 5.1.0). United Kingdom: The Cochrane Collaboration, 2011.

13. Schünemann HJ, Jaeschke R, Cook DJ, et al. An official ATS statement: Grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605–614.

14. Fernández Sanromán J, Fernández Ferro M, Costas López A, Arenaz Bua J, López A. Does injection of plasma rich in growth factors after temporomandibular joint arthroscopy improve outcomes in patients with Wilkes stage IV internal derangement?A randomized prospective clinical study. Int J Oral Maxillofac Surg 2016;45:828–835.

15. Fernández-Ferro M, Fernández-Sanromán J, Blanco-Carrión A, et al. Comparison of intraarticular injection of plasma rich in growth factors versus hyaluronic acid following arthroscopy in the treatment of temporomandibular dysfunction: A randomised prospective study. J Craniomaxillofac Surg 2017; 45:449–454.

16. Cömert Kiliç S, Güngörmüs¸ M, Sümbüllü MA. Is arthrocente-sis plus platelet-rich plasma superior to arthrocentesis alone in the treatment of temporomandibular joint osteoarthritis?A randomized clinical trial. J Oral Maxillofac Surg 2015;73: 1473–1483.

17. Mishra A, Harmon K, Woodall J, Vieira A. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol 2012;13:1185–1195.

18. McNeill C, Mohl ND, Rugh JD, Tanaka TT. Temporomandibular disorders: Diagnosis, management, education, and research. J Am Dent Assoc 1990;120:253.

19. McCain JP, Sanders B, Koslin MG, Quinn JH, Peters PB, Indresano AT. Temporomandibular joint arthroscopy: A 6- year multicenter retrospective study of 4,831 joints. J Oral Maxillofac Surg 1992;50:926–930.

20. Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc 2012;20:2082–2091.

21. Yin W, Qi X, Zhang Y, et al. Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects. J Transl Med 2016;14: 73.

22. Zhou Y, Zhang J, Wu H, Hogan MV, Wang JH, et al. The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells—Implications of PRP application for the clinical treatment of tendon injuries. Stem Cell Res Ther 2015;6:173.

23. Shin KH, Lee H, Kang S, et al. Effect of leukocyte-rich and platelet-rich plasma on healing of a horizontal medial meniscus tear in a rabbit model. Biomed Res Int 2015;2015:179756.